Transcutaneous implantation of valproic acid-encapsulated dissolving microneedles induces hair regrowth

    June 2018 in “Biomaterials
    Shayan Fakhraei Lahiji, Seol Hwa Seo, S. Kim, Manita Dangol, Jiyong Shim, Cheng Guo Li, Yu-Seung Ma, Chisong Lee, Geonwoo Kang, Hyung Kook Yang, Kang Yell Choi, Hyungil Jung
    Image of study
    TLDR Tiny needles with valproic acid can effectively regrow hair.
    The document describes a study that explored the use of valproic acid-encapsulated dissolving microneedles (DMN-VPA) as a treatment for androgenetic alopecia. The study found that DMN-VPA was more effective in delivering valproic acid through the skin and stimulating hair regrowth than topical application. In vivo experiments on mice (7 per group) showed that DMN-VPA treatment resulted in all mice exhibiting hair regrowth, increased hair shaft density and thickness, and a more effective transition from the telogen to anagen phase of hair follicles. The study, which included quantitative analyses with sample sizes of n=20 for hair shaft measurements, n=10 for protein expression analyses, and n=3 for gene expression analyses, concluded that DMN-VPA is a highly effective method for promoting hair regrowth and could be a potential treatment for hair loss conditions like androgenetic alopecia.
    View this study on sciencedirect.com →

    Cited in this study